盐酸左氧氟沙星静脉滴注用于治疗盆腔炎的效果观察

Objective To evaluate the efficacy of intravenous infusion of levofloxacin hydrochloride in treating pelvic inflammatory disease(PID). Methods A total of 40 PID patients admitted to our hospital from November 2023 to November 2024 were selected and divided into the observation group and the control group according to the random number table method, with 20 cases in each group. The control group received standard treatment, while the observation group received levofloxacin hydrochloride infusion in addition to standard therapy. Clinical outcomes were compared including time to clinical symptoms(lower abdominal pain relief, abnormal vaginal discharge improvement, fever resolution), overall treatment effectiveness rate, and changes in inflammatory markers [white blood cell count, C-reactive protein, erythrocyte sedimentation rate(ESR) ] before and after treatment. Results The observation group showed significantly shorter symptom improvement time compared to the control group and the difference was statistically significant(P<0.05). The treatment effectiveness rate in the observation group reached 95.00%, markedly higher than the control group's 70.00% and the difference was statistically significant(P<0.05). Post-treatment, both groups demonstrated significant decreases in inflammatory markers including white blood cell count, C-reactive protein, and ESR, with the observation group showing more pronounced reductions and the difference was statistically significant(P<0.05). Conclusion Intravenous levofloxacin hydrochloride infusion demonstrates significant therapeutic effects in PID treatment, it can improve the treatment effect of patients and prove that this treatment method can be applied in clinical practice.